Clinical Trial Update: Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG) [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating vinblastine with or without bevacizumab in children with unresectable or progressive low grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)
• Vinblastine (vinblastine)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Low Grade Glioma | Phase 2 | Status: ACTIVE_NOT_RECRUITING